000 01385 a2200397 4500
005 20250518073438.0
264 0 _c20200214
008 202002s 0 0 eng d
022 _a1432-0851
024 7 _a10.1007/s00262-019-02447-0
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aJakoš, Tanja
245 0 0 _aLysosomal peptidases in innate immune cells: implications for cancer immunity.
_h[electronic resource]
260 _bCancer immunology, immunotherapy : CII
_cFeb 2020
300 _a275-283 p.
_bdigital
500 _aPublication Type: Journal Article; Review
650 0 4 _aAnimals
650 0 4 _aBiomarkers
650 0 4 _aDendritic Cells
_ximmunology
650 0 4 _aHumans
650 0 4 _aImmunity
650 0 4 _aImmunity, Innate
650 0 4 _aKiller Cells, Natural
_ximmunology
650 0 4 _aLysosomes
_xmetabolism
650 0 4 _aMacrophages
_ximmunology
650 0 4 _aMyeloid-Derived Suppressor Cells
_ximmunology
650 0 4 _aNeoplasms
_xetiology
650 0 4 _aPeptide Hydrolases
_xmetabolism
650 0 4 _aSignal Transduction
650 0 4 _aToll-Like Receptors
_xmetabolism
700 1 _aPišlar, Anja
700 1 _aPečar Fonović, Urša
700 1 _aKos, Janko
773 0 _tCancer immunology, immunotherapy : CII
_gvol. 69
_gno. 2
_gp. 275-283
856 4 0 _uhttps://doi.org/10.1007/s00262-019-02447-0
_zAvailable from publisher's website
999 _c30397020
_d30397020